143 related articles for article (PubMed ID: 10721800)
41. Does exogenous coenzyme Q10 affect aerobic capacity in endurance athletes?
Weston SB; Zhou S; Weatherby RP; Robson SJ
Int J Sport Nutr; 1997 Sep; 7(3):197-206. PubMed ID: 9286743
[TBL] [Abstract][Full Text] [Related]
42. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
[TBL] [Abstract][Full Text] [Related]
43. Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia.
Niklowitz P; Menke T; Wiesel T; Mayatepek E; Zschocke J; Okun JG; Andler W
Clin Chim Acta; 2002 Dec; 326(1-2):155-61. PubMed ID: 12417107
[TBL] [Abstract][Full Text] [Related]
44. High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.
Masotta NE; Martinefski MR; Lucangioli S; Rojas AM; Tripodi VP
Int J Pharm; 2019 Feb; 556():9-20. PubMed ID: 30529659
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration.
Romberg B; Oussoren C; Snel CJ; Carstens MG; Hennink WE; Storm G
Biochim Biophys Acta; 2007 Mar; 1768(3):737-43. PubMed ID: 17223070
[TBL] [Abstract][Full Text] [Related]
46. Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency.
García-Corzo L; Luna-Sánchez M; Doerrier C; Ortiz F; Escames G; Acuña-Castroviejo D; López LC
Biochim Biophys Acta; 2014 Jul; 1842(7):893-901. PubMed ID: 24576561
[TBL] [Abstract][Full Text] [Related]
47. Optimization in the preparation of coenzyme Q10 nanoliposomes.
Xia S; Xu S; Zhang X
J Agric Food Chem; 2006 Aug; 54(17):6358-66. PubMed ID: 16910731
[TBL] [Abstract][Full Text] [Related]
48. Reduction in blood viscosity by treatment with coenzyme Q10 in patients with ischemic heart disease.
Kato T; Yoneda S; Kako T; Koketsu M; Hayano I; Fujinami T
Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):123-6. PubMed ID: 2318549
[TBL] [Abstract][Full Text] [Related]
49. Effect of Coenzyme Q10 supplementation on exercise-induced muscular injury of rats.
Kon M; Kimura F; Akimoto T; Tanabe K; Murase Y; Ikemune S; Kono I
Exerc Immunol Rev; 2007; 13():76-88. PubMed ID: 18198662
[TBL] [Abstract][Full Text] [Related]
50. The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men.
Porter DA; Costill DL; Zachwieja JJ; Krzeminski K; Fink WJ; Wagner E; Folkers K
Int J Sports Med; 1995 Oct; 16(7):421-7. PubMed ID: 8550248
[TBL] [Abstract][Full Text] [Related]
51. Relative bioavailability and antioxidant potential of two coenzyme q10 preparations.
Kurowska EM; Dresser G; Deutsch L; Bassoo E; Freeman DJ
Ann Nutr Metab; 2003; 47(1):16-21. PubMed ID: 12624483
[TBL] [Abstract][Full Text] [Related]
52. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
53. [Effect of coenzyme Q10 on endotoxin induced hepatocyte injury modulation of endotoxin-activated polymorphonuclear neutrophils].
Maruyama H; Furukawa K; Onda M
Nihon Ika Daigaku Zasshi; 1995 Jun; 62(3):271-82. PubMed ID: 7615699
[TBL] [Abstract][Full Text] [Related]
54. Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice.
Sohal RS; Kamzalov S; Sumien N; Ferguson M; Rebrin I; Heinrich KR; Forster MJ
Free Radic Biol Med; 2006 Feb; 40(3):480-7. PubMed ID: 16443163
[TBL] [Abstract][Full Text] [Related]
55. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.
Ishida T; Ichikawa T; Ichihara M; Sadzuka Y; Kiwada H
J Control Release; 2004 Mar; 95(3):403-12. PubMed ID: 15023452
[TBL] [Abstract][Full Text] [Related]
56. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer.
Iinuma H; Maruyama K; Okinaga K; Sasaki K; Sekine T; Ishida O; Ogiwara N; Johkura K; Yonemura Y
Int J Cancer; 2002 May; 99(1):130-7. PubMed ID: 11948504
[TBL] [Abstract][Full Text] [Related]
57. The effect of coenzyme Q10 on sperm motility and function.
Lewin A; Lavon H
Mol Aspects Med; 1997; 18 Suppl():S213-9. PubMed ID: 9266524
[TBL] [Abstract][Full Text] [Related]
58. Comparison of uptake between PureSorb-Q40 and regular hydrophobic coenzyme Q10 in rats and humans after single oral intake.
Nukui K; Yamagishi T; Miyawaki H; Kettawan A; Okamoto T; Sato K
J Nutr Sci Vitaminol (Tokyo); 2007 Apr; 53(2):187-90. PubMed ID: 17616008
[TBL] [Abstract][Full Text] [Related]
59. Suppression in mice of immunosurveillance against PEGylated liposomes by encapsulated doxorubicin.
Yahuafai J; Asai T; Nakamura G; Fukuta T; Siripong P; Hyodo K; Ishihara H; Kikuchi H; Oku N
J Control Release; 2014 Oct; 192():167-73. PubMed ID: 25041998
[TBL] [Abstract][Full Text] [Related]
60. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
